Tag | Content |
---|
EnhancerAtlas ID | HS134-22160 |
Organism | Homo sapiens |
Tissue/cell | Mesendoderm |
Coordinate | chr16:11399890-11400940 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Nr2f6(var.2) | MA0728.1 | chr16:11399955-11399970 | GAGGTCAGGAGTTCA | + | 6.22 | TBX21 | MA0690.1 | chr16:11400556-11400566 | TTCACACCTT | - | 6.02 | Zfx | MA0146.2 | chr16:11399931-11399945 | GAGGCCGAGGCGGG | - | 6.01 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_62053 | chr16:11386770-11424077 | Toledo |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH16I011306 | chr16 | 11400381 | 11411109 |
|
Enhancer Sequence | GCCAGGCGCA GTGGCTCACA CCTGTAATCC CAGAGATTCG GGAGGCCGAG GCGGGCAGAT 60 CACTTGAGGT CAGGAGTTCA AAACCAGCCT GGTCAACATG GCAAATGCTG TCTTTACTAA 120 AAATACAAAA ATTAGCTGGG CATGTTGGCA CATGCCTGTT TTCCCAGCTA CCCAGGAGGC 180 TGAAGCAGGA GAATCGTTTG AACCCAGGAG GTGGAGGCTG CAGTGAGCTG AGATCACGCC 240 ACTACACTCC AGCCTGGGTG ACAGAGTGAG ACTATCTCAA AAAACAACAA CAACAACAAC 300 AAAACCTTTT GTACACCCAT GTTCATAGCA GCACTATTCA CAATAGCCAA AATGTGGAAG 360 CAACCCAGAT GCCCATTAAT GGGTGAATGG ATGAACATGA TGTGGTTTAT ATTAGGTTGG 420 TGCAAAAGTA ATTGTGGTGT TTGCCATTGA AAGTAATGAC AAAAACCGCG ATTACTTTTG 480 CACCAACCTA ATACACATTG CTATGGTCTG AACGCTTGGG CCCTCCGGCA ATGCATATGA 540 TGAAATTCTC ACCCCCACTG TGATGGTGCA TTAGGAGGCG GGGCCTTTGG AAGGTGATTA 600 GTTCATGAGG GCACAGCCCT CATGAATGGG ATTAGCACCC TTATAAAACA ATCCCATGAG 660 AACGGGTTCA CACCTTTCGC CATTAAAGAT CCAACAAGAA TCCTTCTTTC CGGTCTGTGA 720 ACCAATAAAC AGGCCCCCAG CAGACATTGG ATCTGCCAGC ACCTTCATCT TGGACTTTTC 780 AGCCTCCAGA ACTGTAAGAA ATAAACGTTT GGCCGGGTGC AGTGGCTCAT GCCTCTAATC 840 CCAGCACTTT GGGAGATCCG AGGCAGACAG ATCACCTGAG GGAAGGAGTT CAAGACCAGC 900 CTGGCCAACA TGATGAAACT CCGTCTCTCC TAAAAGTACA AACATTGCCC AGGTGTGGTG 960 GTGGGCGTCT GTAATCCCAG CCACTCGGGA GGCTGAGGCA GGAGAATCAC TTGAACCTGG 1020 AGGCGGAGGT TGTAGTAAGC TGAGATTGCA 1050
|